Two-year follow-up after bioresorbable vascular scaffold
implantation in STEMI patients - Results from PRAGUE-19 study

J 2016

Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Petr ROBERT et al.

Základní údaje

Originální název

Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study

Autoři

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Petr ROBERT; Martin HAJŠL; Jiří JARKOVSKÝ a Petr WIDIMSKÝ

Vydání

International Journal of Cardiology, Clare, Elsevier Ireland Ltd. 2016, 0167-5273

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 6.189

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00090375

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Bioresorbable vascular scaffold; STEMI; Long-term follow-up; Dual antiplatelet treatment termination

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 4. 8. 2016 16:24, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Several studies have shown early andmid-termsafety and feasibility of everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in different clinical settings including patients with ST-elevationmyocardial infarction (STEMI). Favourable long-term clinical results have been shown in stable patients. Recently, one year clinical follow-up has been presented in STEMI patients with very encouraging results. On the other hand, the rate of early and mid-term stent thrombosis during dual antiplatelet treatment (DAPT) in this clinical setting is not negligible. Clinical outcome of STEMI patientswith implanted BVS after DAPT termination is not known. Thus, we sought to evaluate a 2 year clinical follow-up of patients included in the pilot phase of PRAGUE-19 study with published short-term clinical results.

Citovat

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Petr ROBERT; Martin HAJŠL; Jiří JARKOVSKÝ a Petr WIDIMSKÝ. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. International Journal of Cardiology. Clare: Elsevier Ireland Ltd., 2016, roč. 209, "neuvedeno", s. 20-21. ISSN 0167-5273. Dostupné z: https://doi.org/10.1016/j.ijcard.2016.02.029.

@article{1349621,
   author = {Toušek, Petr and Kočka, Viktor and Malý, Martin and Kozel, Martin and Robert, Petr and Hajšl, Martin and Jarkovský, Jiří and Widimský, Petr},
   article_location = {Clare},
   article_number = {"neuvedeno"},
   doi = {https://doi.org/10.1016/j.ijcard.2016.02.029},
   keywords = {Bioresorbable vascular scaffold; STEMI; Long-term follow-up; Dual antiplatelet treatment termination},
   language = {eng},
   issn = {0167-5273},
   journal = {International Journal of Cardiology},
   title = {Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study},
   volume = {209},
   year = {2016}
}

TY  - JOUR
ID  - 1349621
AU  - Toušek, Petr - Kočka, Viktor - Malý, Martin - Kozel, Martin - Robert, Petr - Hajšl, Martin - Jarkovský, Jiří - Widimský, Petr
PY  - 2016
TI  - Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study
JF  - International Journal of Cardiology
VL  - 209
IS  - "neuvedeno"
SP  - 20-21
EP  - 20-21
PB  - Elsevier Ireland Ltd.
SN  - 01675273
KW  - Bioresorbable vascular scaffold
KW  - STEMI
KW  - Long-term follow-up
KW  - Dual antiplatelet treatment termination
N2  - Several studies have shown early andmid-termsafety and feasibility of everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in different clinical settings including patients with ST-elevationmyocardial infarction (STEMI). Favourable long-term clinical results have been shown in stable patients. Recently, one year clinical follow-up has been presented in STEMI patients with very encouraging results. On the other hand, the rate of early and mid-term stent thrombosis during dual antiplatelet treatment (DAPT) in this clinical setting is not negligible. Clinical outcome of STEMI patientswith implanted BVS after DAPT termination is not known. Thus, we sought to evaluate a 2 year clinical follow-up of patients included in the pilot phase of PRAGUE-19 study with published short-term clinical results.
ER  -

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Petr ROBERT; Martin HAJŠL; Jiří JARKOVSKÝ a Petr WIDIMSKÝ. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. \textit{International Journal of Cardiology}. Clare: Elsevier Ireland Ltd., 2016, roč.~209, ''neuvedeno'', s.~20-21. ISSN~0167-5273. Dostupné z: https://doi.org/10.1016/j.ijcard.2016.02.029.

Přehled o publikaci